<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In 2009 in the United States, <z:hpo ids='HP_0003002'>breast cancer</z:hpo> was the most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in women, and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> was the third most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in both men and women </plain></SENT>
<SENT sid="1" pm="."><plain>Currently, over 40% of these <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> are diagnosed at an advanced stage, which results in higher morbidity and mortality than would obtain with optimal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> screening utilization </plain></SENT>
<SENT sid="2" pm="."><plain>To provide information that might improve these <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> outcomes we use spatial analysis to answer questions related to both Why and Where disparities in late-stage <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnoses are observed </plain></SENT>
<SENT sid="3" pm="."><plain>In examining Why, we include state level characteristics reflecting characteristics of states' <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> control planning, insurance markets and managed care environments to help model the spatial <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> from place to place </plain></SENT>
<SENT sid="4" pm="."><plain>To answer questions related to Where disparities are observed, we generate county level predictions of late-stage <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> rates from a random-intercept multilevel model estimated on the population data from 11 pooled SEER Registries </plain></SENT>
<SENT sid="5" pm="."><plain>The findings allow for comparisons across states that reveal logical starting points for a national effort to control <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>